Drugs & Drug Overdoses: Data & Alerts from CDC
Increases in Availability of Cannabis Products Containing Delta-8 THC and Reported Cases of Adverse Events
The purpose of this Health Alert Network (HAN) Health Advisory is to alert public health departments, healthcare professionals, first responders, poison control centers, laboratories, and the public to the increased availability of cannabis products containing delta-8 tetrahydrocannabinol (THC) and the potential for adverse events due to insufficient labeling of products containing THC and cannabidiol (CBD).
Additional Data from CDC
For every drug overdose that results in death, there are many more nonfatal overdoses, each one with its own emotional and economic toll.
- Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential Among Racial and Ethnic Groups – United States, 2004–2019 (Drug and Alcohol Dependence)
- Cannabis Adult-use Sales Increase during COVID-19: Findings from Alaska, Colorado, Oregon, and Washington (International Journal of Drug Policy)
- Trends in Nonfatal and Fatal Overdoses Involving Benzodiazepines — 38 States and the District of Columbia, 2019–2020 (MMWR)
- Notes from the Field: Illicit Benzodiazepines Detected in Patients Evaluated in Emergency Departments for Suspected Opioid Overdose — Four States, October 6, 2020–March 9, 2021 (MMWR)
- More publications
Data Bites & Shareable Graphics
Over 90% of benzodiazepine-involved overdose deaths also involved opioids from January 2019 to June 2020.
As many as 1 in 4 people receiving prescription opioids long term in a primary care setting struggles with addiction.